Last $2.30 USD
Change Today -0.04 / -1.71%
Volume 38.4K
CDXS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Alan Shaw Ph.D.

Special Advisor, Codexis, Inc.
AgeTotal Calculated CompensationThis person is connected to 104 board members in 2 different organizations across 5 different industries.

See Board Relationships
50--
As of Fiscal Year 2012

Background*

Dr. Alan Shaw, PhD, serves as the Chairman, Chief Executive Officer and President at Calysta, Inc. Dr. Shaw has been Special Advisor to the board of directors Codexis Inc. since February 17, 2012. Dr. Shaw served as the Chairman of the Board and Chief Scientific Officer of VaxInnate, Inc. since March 2010. He served as the President of Codexis Inc., a subsidiary of Maxygen Inc. from August 2001 to February 17, 2012 and its Chief Executive Officer since October 2002 until ...

Read Full Background

Corporate Headquarters*

200 Penobscot Drive
Redwood City, California 94063

United States

Phone: 650-421-8100
Fax: --

Board Members Memberships*

Former Chairman and Chief Scientific Officer
Chairman, Chief Executive Officer and President
2002-2012
Special Advisor
2009-2012
Former Director

Education*

PhD
Medical University of Ohio
PhD
Durham University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CDXS:US $2.30 USD -0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Steven M. Klosk Chief Executive Officer, President and Director
Cambrex Corporation.
$533.3K
Feike Sijbesma Chairman of Managing Board, Chief Executive Officer and Chairman of DSM Nutritional Products
Koninklijke DSM N.V.
€1.4M
Satoshi Masumura Chief Executive Officer, President and Director
Takasago International Corporation
--
Peder Holk Nielsen Chief Executive Officer and President
Novozymes A/S
kr8.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CODEXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.